Adynovate
Payments companies reported to CMS as associated with Adynovate. "Associated with" is CMS's wording: it links a payment to a product without saying the money was spent on it.
By year
Payments reported as associated with Adynovate, per program year, as reported to CMS.
Who makes it
Specialties most often involved
Where the associated payments went, by the receiving clinician's specialty.
Clinicians most associated with Adynovate
These are the largest totals companies reported as associated with Adynovate. They are typically speaking or consulting arrangements, which companies must report by law; appearing here is not evidence of anything improper.
| Clinician | Location | Specialty | Associated payments (2023-2025) |
|---|---|---|---|
| Leonard Valentino | Chicago, IL | Pediatric Hematology-Oncology | $11,316.76 |
| Robert Sidonio | Atlanta, GA | Pediatric Hematology-Oncology | $6,572.66 |
| Shayla Bergmann | Beaufort, SC | Pediatric Hematology-Oncology | $3,360.66 |
| Vinod Balasa | Madera, CA | Pediatric Hematology-Oncology | $3,360.66 |
| Veronica Flood | Milwaukee, WI | Pediatric Hematology-Oncology | $3,360.66 |
| Tammuella Chrisentery-Singleton | New Orleans, LA | Pediatric Hematology-Oncology | $3,360.66 |
| Jordan Shavit | Ann Arbor, MI | Pediatric Hematology-Oncology | $3,360.66 |
| Fernando Corrales-Medina | Miami, FL | Pediatric Hematology-Oncology | $3,360.66 |
| Mahendra Patel | San Antonio, TX | Pediatric Hematology-Oncology | $97.08 |
| Roberto Canales | El Paso, TX | Pediatric Hematology-Oncology | $66.03 |
Prescribed Adynovate?
See what its makers reported for your doctor. Two steps, private, no account.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.